Induction of transplantation tolerance in non-human primate preclinical models

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 360, Issue 1461, 2005, Pages 1723-1737

  Hale, Douglas A ^a,b   Dhanireddy, Kiran ^a   Bruno, David ^a   Kirk, Allan D ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Building 10 ^*  (United States)

Author keywords

Chimerism; Costimulation; Cynomolgus; Rhesus; Tolerance; Transplantation

Indexed keywords

CANCER; DISEASE INCIDENCE; DISEASE TREATMENT; IMMUNE SYSTEM; PRIMATE; TRANSPLANTATION;

PRIMATES; RODENTIA;

LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; PRIMATE; REVIEW; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; IMMUNOSUPPRESSION; MODELS, ANIMAL; MODELS, IMMUNOLOGICAL; PRIMATES; SIGNAL TRANSDUCTION; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 33644832365     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2005.1703     Document Type: Review

References (142)

1. Adams, A. B. et al. 2002 Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 51, 265-270.
2. Adams, A. B., Pearson, T. C. & Larsen, P. 2003a Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196, 147-160. (doi:10.1046/j.1600-065X.2003.00082.x.)
3. Adams, A. B. et al. 2003b Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111, 1887-1895. (doi:10.1172/JCI200317477.)
4. Adorini, L. et al. 2003 Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell Biochem. 88, 227-233. (doi:10.1002/jcb.10340.)
5. Alexander, J. W. et al. 1998 Arginine fish oil, and donor-specific transfusions independently improve cardiac allograft survival in rats given subtherapeutic doses of cyclosporin, JPEN. J. Parenter. Enteral Nutr. 22, 152-155.
6. Allegra, F. & Giacomett, L. 1968a Skin homografts in rhesus monkeys (Macaca mulatta): first and second rejection. 1. Technical and clinical findings. Acta Dermatol. Venereol. 48, 429-434.
7. Allegra, F. & Giacometti, L. 1968b Skin homografts in rhesus monkeys (Macaca mulatta): first and second rejection. 2. Histology and histochemistry. Acta Dermatol. Venereol. 48, 435-452.
8. Allegra, F., Bell, M. & Giacometti, L. 1968 Skin homografts in rhesus monkeys (Macaca mulatta): first and second rejection. 3. The immunologically competent cells: electron microscopy and DNA synthesis. Acta Dermatol. Venereol. 48, 453-464.
9. Angelisova, P. et al. 1983 Adult transplantation tolerance induced by lentil lectin. I. The fate of tolerogenic lentil seed lectin after injection into mice. Folia Biol. (Praha) 29, 230-237.
10. Armstrong, N. et al. 1998 Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 66, 5-13. (doi:10.1097/00007890-199807150-00002.)
11. Bashuda, H. et al. 1996 Induction of persistent allograft tolerance in the rat by combined treatment with antileukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies donor-specific transfusion, and FK506. Transplantation 62, 117-122. (doi:10.1097/00007890- 199607150-00022.)
12. Bieber, C. P. et al. 1979 Cardiac allograft survival in rhesus primates treated with combined total lymphoid irradiation and rabbit antithymocyte globulin. Transplantation 28, 347-350.
13. Binns, R. M., Calne, R. Y. & Millard, R. 1970 Induced tolerance of a kidney allograft in a pig. Preliminary report. Eur. Surg. Res. 2, 408-414.
14. Birsan, T. et al. 2003 Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Transplantation 75, 2106-2113. (doi:10.1097/01.TP. 0000066806.10029.7A.)
15. Blair, P. J. et al. 2000 CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191, 651-660. (doi:10.1084/jem.191.4.651.)
16. Brandt, M. et al. 1997 Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection. Transplant. Int. 10, 141-144. (doi:10.1007/s001470050028.)
17. Brendel, M. D. et al. 1995 The influence of donor specific vertebral body derived bone marrow cell infusion on canine islet allograft survival without irradiation conditioning of the recipient. Exp. Clin. Endocrinol. Diabetes 103(Suppl. 2), 129-132.
18. Buhler, L. H. et al. 2002 Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74, 1405-1409. (doi:10.1097/00007890- 200211270-00011.)
19. Calne, R. et al. 1998 Prope tolerance perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351, 1701-1702. (doi:10.1016/S0140-6736(05)77739-4.)
20. Chavin, K. D. et al. 1993 Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. Ann. Surg. 218, 492-501.
21. Chiffoleau, E. et al. 2002 Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T-cell differentiation. Am. J. Transplant. 2, 745-757. (doi:10.1034/j.1600-6143.2002.20808.x.)
22. Chikaraishi, T. et al. 1995 Effect of 15-deoxyspergualin (DSG) on rat kidney allograft: immunological mechanisms implicated in prolonged survival. J. Urol. 154, 2197-2202. (doi:10.1097/00005392-199512000-00060.)
23. Cho, C. S. et al. 2001 Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. Transplantation 72, 587-597. (doi:10.1097/00007890-200108270-00006.)
24. Conti, D. J. & Cosimi, B. 1990 Effect of monoclonal antibodies on primate allograft rejection. Crit. Rev. Immunol. 10, 113-130.
25. Contreras, J. L. et al. 1998 Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation 65, 1159-1169. (doi:10.1097/00007890-199805150-00003.)
26. Cosimi, A. B. et al. 1990 Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 108, 406-413.
27. Davis Jr, J. C. et al. 2001 Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus. J. Rheumatol. 28, 95-101.
28. Elster, E. A. et al. 2001a Primate skin allotransplantation with anti-CD154 monotherapy. Transplant. Proc. 33, 675-676. (doi:10.1016/S0041- 1345(00)02197-7.)
29. Elster, E. A. et al. 2001b Treatment with the humanized CD154-specific monoclonal antibody hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 72, 1473-1478. (doi:10.1097/00007890- 200111150-00001.)
30. Fechner Jr, J. H. et al. 1997a Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation 63, 1339-1345. (doi:10.1097/00007890-199705150-00023.)
31. Fechner Jr, J. H. et al. 1997b Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. Transplant. Proc. 29, 1158. (doi:10.1016/S0041-1345(96)00503-9.)
32. Fechner Jr, J. H. et al. 2001 Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. Transplantation 72, 581-587. (doi:10.1097/00007890-200108270- 00005.)
33. Gao, Z. et al. 1999 Adoptively transferable tolerance induced by CD45RB monoclonal antibody. J. Am. Soc. Nephrol. 10, 374-381.
34. Gimmi, C. D. et al. 1993 Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA 90, 6586-6590.
35. Goss, J. A., Nakafusa, Y. & Flye, W. 1992 Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. Ann. Surg. 216, 409-414.
36. Gregori, S. et al. 2001 Regulatory T cells induced by 1 alpha25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953.
37. Guo, L. et al. 2003 Simultaneous blockade of co-stimulatory signals CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transplant. Immunol. 12, 41-48. (doi:10.1016/S0966-3274(03)00016-9.)
38. Gutstein, N. L. et al. 1986 Induction of immune tolerance by administration of monoclonal antibody to L3T4. J. Immunol. 137, 1127-1132.
39. Hariharan, S. et al. 2000 Improved graft survival after renal transplantation in the United States 1988 to 1996. N. Engl. J. Med. 342, 605-612. (doi:10.1056/NEJM200003023420901.)
40. Hausen, B. et al. 2001 Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys. Transplantation 72, 1128-1137. (doi:10.1097/00007890- 200109270-00025.)
41. Hayamizu, K. et al. 1998 Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 66, 1285-1291. (doi:10.1097/00007890-199811270-00004.)
42. Iwakoshi, N. N. et al. 2000 Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J. Immunol. 164, 512-521.
43. Jin, Y. Z., Zhang, Q. Y. & Xie, S. 2003 Low-dose donor bone marrow cells and splenocytes plus adenovirus encoding for CTLA4Ig gene promote stable mixed chimerism and long-term survival of rat cardiac allografts. Transplant. Proc. 35, 3156-3159. (doi:10.1016/j.transproceed.2003.10.025.)
44. Jirsch, D. W., Kraft, N. & Diener, E. 1974 Tolerance induction to a heterotopic cardiac allograft in the irradiated reconstituted mouse. Transplantation 18, 155-162.
45. Johnson, J. G. & Jenkins, K. 1993 Accessory cell-derived signals required for T cell activation. Immunol. Res. 12, 48-64.
46. Jones, T. R. et al. 2002 The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. J. Immunol. 168, 1123-1130.
47. June, C. H. et al. 1994 The B7 and CD28 receptor families. Immunol. Today 15, 321-331. (doi:10.1016/0167-5699(94)90080-9.)
48. Kawai, T. et al. 1995 Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59, 256-262.
49. Kawai, T. et al. 1999 Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68, 1767-1775. (doi:10.1097/00007890-199912150-00022.)
50. Kawai, T. et al. 2000 Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation 70, 368-374. (doi:10.1097/00007890-200007270-00023.)
51. Kawai, T. et al. 2001 Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation 72, 351-354. (doi:10.1097/00007890-200107270-00036.)
52. Kawai, T. et al. 2002 Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 73, 1757-1764. (doi:10.1097/00007890-200206150-00011.)
53. Kawai, T. et al. 2004 CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am. J. Transplant. 4, 1391-1398. (doi:10.1111/j.1600-6143.2004.00523.x.)
54. Kenyon, N. S. et al. 1999a Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl Acad. Sci. USA 96, 8132-8137. (doi:10.1073/pnas.96.14. 8132.)
55. Kenyon, N. S. et al. 1999b Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 48, 1473-1481.
56. Kimikawa, M. et al. 1997a Mixed chimerism and transplantation tolerance induced by a nonlethal preparative regimen in cynomolgus monkeys. Transplant. Proc. 29, 1218. (doi:10.1016/S0041-1345(96)00642-2.)
57. Kimikawa, M. et al. 1997b Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 64, 709-716. (doi:10.1097/00007890-199709150-00008.)
58. Kirk, A. D. 2003 Crossing the bridge: large animal models in translational transplantation research. Immunol. Rev. 196, 176-196. (doi:10.1046/j.1600-065X.2003.00081.x.)
59. Kirk, A. D. et al. 1997 CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad. Sci. USA 94, 8789-8794. (doi:10.1073/pnas.94.16.8789.)
60. Kirk, A. D. et al. 1999 Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5, 686-693. (doi:10.1038/9536.)
61. Kirk, A. D. et al. 2001a Preliminary results of the use of humanized anti-CD154 in human renal allotransplantation. Am. J. Transplant. 1(Suppl. 1), 191.
62. Kirk, A. D. et al. 2001b Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 72, 377-384. (doi:10.1097/00007890- 200108150-00005.)
63. Kirk, A. D. et al. 2003 Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76, 120-129. (doi:10.1097/01.TP.0000071362.99021. D9.)
64. Kirk, A. D. et al. 2005 Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation. In press.
65. Knapp, L. A. et al. 1997a Identification of new mamu-DRB alleles using DGGE and direct sequencing. Immunogemtics 45, 171-179. (doi:10.1007/ s002510050186.)
66. Knapp, L. A. et al. 1997b High frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens 50, 657-661.
67. Knechtle, S. J. 2001 Treatment with immunotoxin. Phil. Trans. R. Soc. B 356, 681-689. (doi:10.1098/rstb.2001.0839.)
68. Knechtle, S. J. & Burlingham, J. 2004 Metastable tolerance in nonhuman primates and humans. Transplantation 77, 936-939. (doi:10.1097/01.TP. 0000117777.70887.3C.)
69. Knechtle, S. J. et al. 1997 FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 63, 1-6. (doi:10.1097/00007890- 199701150-00002.)
70. Knechtle, S. J. et al. 1999 Inducing unresponsiveness by the use of anti-CD3 immunotoxin CTLA4-Ig, and anti-CD40 ligand. Transplant. Proc. 31 (Suppl. 3B), 27-28. (doi:10.1016/S0041-1345(99)00100-1.)
71. Knechtle, S. J. et al. 2003 Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am. J. Transplant. 3, 722-730. (doi:10.1034/j.1600-6143.2003.00120.x.)
72. Koyama, I. et al. 2004 Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation 77, 460-462. (doi:10.1097/01.TP.0000110291.29370.C0.)
73. Kozlowski, T. et al. 1999 Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 67, 18-30. (doi:10.1097/00007890-199901150-00004.)
74. Lance, E. M. & Medawar, B. 1970b Antilymphocyte serum and the induction of tolerance to transplantation antigens. Fed. Proc. 29, 151-152.
75. Lance, E. M. & Medawar, B. 1970a Immunosuppressive effects of heterologous antilymphocyte serum in monkeys. Lancet 1, 167-170. (doi:10.1016/S0140-6736(70)90407-1.)
76. Larsen, C. P. et al. 1996 Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438. (doi:10.1038/381434a0.)
77. Lehmann, M. et al. 1997 Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 64, 1181-1187. (doi:10.1097/00007890-199710270-00017.)
78. Lenschow, D. J. et al. 1992 Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257, 789-792.
79. Lenschow, D. J. et al. 1995 Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 60, 1171-1178.
80. Levisetti, M. G. et al. 1997 Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159, 5187-5191.
81. Lindner, J. K. & Zantl, N. 1998 Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival. Transpl. Int. 11(Suppl. 1), 303-309. (doi:10.1007/s001470050484.)
82. Linley, W. et al. 1998 Changes in T-cell subsets after renal transplantation in nonimmunosuppressed baboons. Transplant. Proc. 30, 1163. (doi:10.1016/S0041-1345(98)00191-2.)
83. Markees, T. G. et al. 1998 Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 101, 2446-2455.
84. Meier-Kriesche, H. U. et al. 2004 Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4, 378-383. (doi:10.1111/j.1600-6143.2004.00332.x.)
85. Montgomery, S. P. et al. 2001 Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates. Immunol. Rev. 183, 214-222. (doi:10.1034/j.1600-065x.2001.1830117.x.)
86. Montgomery, S. P. et al. 2002a Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model, Am. J. Transplant. 2, 381-385. (doi:10.1034/j.1600-6143.2002.20415.x.)
87. Montgomery, S. P. et al. 2002b Combination induction therapy with monoclonal antibodies specific for CD80 CD86, and CD154 in nonhuman primate renal transplantation. Transplantation 74, 1365-1369. (doi:10.1097/00007890- 200211270-00002.)
88. Mourad, G. J. et al. 1998 Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation 65, 632-641. (doi:10.1097/00007890-199803150-00006.)
89. Myburgh, J. A. & Smit, A. 1972 Passive and active enhancement in baboon liver allografting. Transplantation 14, 227-235.
90. Myburgh, J. A. & Smit, A. 1973 Enhancement and antigen suicide in the outbred primate. Transplant. Proc. 5, 597-600.
91. Myburgh, J. A. & Smit, A. 1979 Autoantiidiotypic immunization and transplantation tolerance in the primate. Transplant. Proc. 11, 923-927.
92. Myburgh, J. A. et al. 1971 Hepatic allotransplantation in the baboon. 3. The effects of immunosuppression and administration of donor-specific antigen after transplantation. Transplantation 12, 202-210.
93. Myburgh, J. A. et al. 1980a Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. I. Orthotopic liver allografts. Transplantation 29, 401-404.
94. Myburgh, J. A. et al. 1980b Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. II. Renal allografts. Transplantation 29, 405-408.
95. Myburgh, J. A., Smit, J. A. & Browde, S. 1981 Transplantation tolerance in the primate following total lymphoid irradiation (TLI) and bone marrow (BM) injection. Transplant. Proc. 13, 434-438.
96. Myburgh, J. A. et al. 1984 Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens. J. Immunol. 132, 1019-1025.
97. Nanji, S. A. et al. 2003 Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival. Transplant. Proc. 35, 2477-2478. (doi:10.1016/j.transproceed.2003.08.029.)
98. Neville Jr, D. M., Scharff, J. & Srinivasachar, K. 1992 In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc. Natl Acad. Sci. USA 89, 2585-2589.
99. Nocera, A. et al. 1989 Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies. Transplantation 48, 732-741.
100. Oike, F. et al. 2000 A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. Transplantation 69, 2304-2314. (doi:10.1097/00007890-200006150-00014.)
101. Parker, D. C. et al. 1995 Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl Acad. Sci. USA 92, 9560-9564.
102. Pearson, T. C. et al. 2002 Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 74, 933-940. (doi:10.1097/00007890- 200210150-00006.)
103. Pennock, J. L. et al. 1981 Survival of primates following orthotopic cardiac transplantation treated with total lymphoid irradiation and chemical immune suppression. Transplantation 32, 467-473.
104. Pfeiffer, S. et al. 2001 Monotherapy with anti-CD40 ligand antibody (IDEC 131) for non-human primate allograft heart transplantation. J. Heart Lung Transplant. 20, 250. (doi:10.1016/S1053-2498(00)00568-4.)
105. Pierson III, R. N. et al. 1999 Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody. Transplantation 68, 1800-1805. (doi:10.1097/00007890-199912150-00026.)
106. Pierson III, R. N. et al. 2001 CD40-ligand in primate cardiac allograft and viral immunity. Immunol. Res. 23, 253-262. (doi:10.1385/IR:23:2-3:253.)
107. Posselt, A. M. et al. 1990 Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249, 1293-1295.
108. Powelson, J. A. et al. 1994 CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation 57, 788-793.
109. Preston, E. H. et al. 2005 IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am. J. Transplant. 5, 1032-1041.
110. Ringers, J. et al. 2002 Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates. Transplantation 73, 862-866. (doi:10.1097/ 00007890-200203270-00006.)
111. Rossini, A. A. et al. 1996 Induction of immunological tolerance to islet allografts. Cell Transplant. 5, 49-52. (doi:10.1016/0963-6897(95)02010-1.)
112. Schuurman, H. J., Kuhn, E. M. & Jonker, M. 1997a Chronic rejection in rhesus monkey kidney allografts. Transplant. Proc. 29, 2546-2547. (doi:10.1016/S0041-1345(97)00501-0.)
113. Schuurman, H. J. et al. 1997b Preclinical models of chronic rejection: promises and pitfalls. Transplant. Proc. 29, 2624-2625. (doi:10.1016/S0041- 1345(97)00533-2.)
114. Sogawa, H. et al. 2001 Comparison of horse antithymocyte globulin with other T cell-depleting antibodies for induction of chimerism and renal allograft tolerance in nonhuman primates. Transplant. Proc. 33, 116-117. (doi:10.1016/S0041-1345(00)01933-3.)
115. Stark, J. H., Smit, J. A. & Myburgh, A. 1994 Nonspecific mixed lymphocyte culture inhibitory antibodies in sera of tolerant transplanted baboons conditioned with total lymphoid irradiation. Transplantation 57, 1103-1110.
116. Sykes, M. & Sachs, H. 1988 Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol. Today 9, 23-27. (doi:10.1016/0167- 5699(88)91352-7.)
117. Sykes, M. & Sachs, H. 1990 Bone marrow transplantation as a means of inducing tolerance. Semin. Immunol. 2, 401-417.
118. Thomas, J. M., Carver, F. M. & Thomas, T. 1979 Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells. Surg. Forum 30, 282-283.
119. Thomas, F. T. et al. 1983a Long-term incompatible kidney survival in outbred higher primates without chronic immunosuppression. Ann. Surg. 198, 370-378.
120. Thomas, J. M. et al. 1983b Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 36, 104-106.
121. Thomas, J. M. et al. 1989 Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs. Transplantation 47, 209-215.
122. Thomas, J. M. et al. 1991 Kidney allograft tolerance in primates without chronic immunosuppression - the role of veto cells. Transplantation 51, 198-207.
123. Thomas, J. M. et al. 1994 Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 57, 101-115.
124. Thomas, J. M. et al. 1997 Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow - induces operational tolerance to kidney allografts. Transplantation 64, 124-135. (doi:10.1097/00007890-199707150-00022.)
125. Thomas, J. M. et al. 1999 Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68, 1660-1673. (doi:10.1097/00007890-199912150- 00009.)
126. Thomas, J. M. et al. 2000 Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 69,2497-2503. (doi:10.1097/00007890-200006270-00007.)
127. Thomas, J. M. et al. 2001 STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol. Rev. 183, 223-233. (doi:10.1034/j.1600- 065x.2001.1830118.x.)
128. Torrealba, J. R. et al. 2003 Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation 76, 524-530. (doi:10.1097/01.TP.0000075788.72614.D4.)
129. Torrealba, J. R. et al. 2004 Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+T regulatory cell infiltrates. J. Immunol. 172, 5753-5764.
130. Watson, C. J. et al. 1993 CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog. Br. J. Surg. 80, 1389-1392.
131. Wee, S. et al. 1994 Anti-CD4 mAb therapy significantly delays the alloantibody response in a cynomolgus renal transplant model. Transplantation 58, 261-264.
132. Wekerle, T. & Sykes, M. 1999 Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 68, 459-467. (doi:10.1097/00007890-199908270-00001.)
133. Wekerle, T. et al. 1998 Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187, 2037-2044. (doi:10.1084/jem.187.12.2037.)
134. Wekerle, T. et al. 1999a Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade. Transplant. Proc. 31, 680. (doi:10.1016/S0041-1345(98)01605-4.)
135. Wekerle, T. et al. 1999b Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 68, 1348-1355. (doi:10.1097/00007890-199911150-00022.)
136. Wells, A. D. et al. 1999 Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5, 1303-1307. (doi:10.1038/8466.)
137. Wood, M. L. et al. 1971 Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant. Proc. 3, 676-679.
138. Xu, H. et al. 2001 Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Transplant. Proc. 33, 223-224. (doi:10.1016/S0041-1345(00)01983-7.)
139. Xu, H. et al. 2003a Effects of combined treatment with. Am. J. Transplant. 3, 1350-1354. (doi:10.1046/j.1600-6135.2003.00235.x.)
140. Xu, H. et al. 2003b Studies investigating pretransplant donor-specific blood transfusion rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation. J. Immunol. 170, 2776-2782.
141. Yang, H., Issekutz, T. B. & Wright Jr, R. 1995 Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1. Transplantation 60, 71-76.
142. Zhang, Z. et al. 2000 Prolongation of xenograft survival using monoclonal antibody CD45RB and cyclophosphamide in rat-to-mouse kidney and heart transplant models. Transplantation 69, 1137-1146. (doi:10.1097/00007890- 200003270-00019.)